Τόμος 11 (1997) – Τεύχος 2 & 3 – Άρθρο 21 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 11 (1997) – Issue 2 & 3 – Article 21 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Differences in backbone structure between the super agonist [Sar1] angiotensin II and its type I antagonist sarilesin
Authors J.M. Matsoukas1, K. Alexopoulos1, T. Tselios1, P. Roumelioti1, R. Yamdagni2, Q. Wu2, T. Mavromoustakos3, E. Kalatzis3, E. Siapi3 and G.J. Moore4

1. Department of Chemistry, University of Patras, Patras 26500, Greece

2. Department of Chemistry, University of Calgary, Calgary Alberta, Canada T2N 4N1

3. Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Athens 11635, Greece

4. Department of Pharmacology and Therapeutics, University of Calgary, Calgary Alberta T2N 4N1, Canada

Citation Matsoukas, J.M., Alexopoulos, K., Tselios, T., Roumelioti, P., Yamdagni, R. et al.: Differences in backbone structure between the super agonist [Sar1] angiotensin II and its type I antagonist sarilesin, Epitheorese Klin. Farmakol. Farmakokinet. 11(2-3): 132-136 (1997)
Publication Date 1997
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords [Sar1] Angiotensin II, super agonist, type 1 antagonist, Sarilesin, backbone structure
Other Terms review article
Summary Conformational investigation of the backbone structure of the super agonist [Sar¹] Angiotensin II and its type I antagonist Sarilesin by one-dimensional Nuclear Overhauser Effect (NOE) spectroscopy revealed that the Tyr-lle-His bend, a conformational property found in ANG H and [Sar1] ANG H is not present in Sarilesin and type I antagonists. In particular, very strong enhancements (17-22%) of Tyr Cα proton resonance in [Sar¹] ANG II upon irradiation of the His Cα proton resonance and vice versa, revealed that Tyr-lle-His bend is a predominant feature of the conformation of the agonist in the receptor simulating environments provided by DMSO-d6 and DMSO-d6/D20 (9/1). In contrast, saturation of the His CQ proton NOE enhancements, illustrating the absence of a Tyr-lle-His bend in the antagonist peptide. The present findings reveal that the phenylalanine ring in the c-terminal residue of the super agonist [Sar¹] ANG II appears to have an essential role in generating the biologically active conformation of the hormone in which the Tyr-lle-His bend is an important structural element allowing a ring duster which triggers activity. Furthermore these data provide for the first time an important backbone conformational difference between [Sar1] ANG II and Sarilesin even they differ chemically, only in the C-terminal residue which is aromatic for the agonist and aliphatic for the antagonist peptides.
References 1.   Ondetti M.A., Cushman D.W.: Annu. Rev. Biochem. 51: 283-308 (1981)

2.  Turker R.K., Hall M.M., Yamamoto M., Sweet C.S., Bumpus F.M.: Science 177: 1203-1205 (1972)

3.  Turner R.J., Matsoukas J.M., Moore G.J.: Biochim. Biophys. Acta 1065: 21-28 (1991)

4.  Matsoukas J.M., Hondrelis J., Keramlda M., Mavromoustakos T., Makriyannis A., Yamdagni R., Wu Q.. Moore G.J.: J. Btoi. Chem. 269: 5303-5312 (1994)

5.  Matsoukas J.M., Bigam G., Zhou N., Moore G.J: Peptides 11: 359-366 (1990)

6.  Matsoukas J.M., Yamdagni R., Moore G. J.: Pepfkies 11: 367-374 (1990)

7.   Matsoukas J.M., Agelis G., Wahhab A., Hondrelis J., Panagiotopoulos D., Yamdagni R., Wu Q., Mavromoustakos T., Maia H., Ganter R., Moore G.J.: J. med. Chem. 38: 4660-4669 (1995)

8.  Duncia J.V., Chiu A.T., Carini D.J., Gregory G.B., Johnson A.L., Price W.A., Wells G.J., Wong P.C., Calabrese J.C., Timmermans P.B.M.W.: J. Med. Chem. 33: 1312-1329 (1990)

9.  Carini D.J., Duncia J.V., Aldrich P.E., Chiu A.T., Johnson A.L, Poerce M.E., Price W.A., Santella J.B., III, Welle G.J., Wexler R.R., Wong P.C., Yoo S.E., Timmermans P.B.M.W.M.: J. Med. chem. 34: 2525-2547 (1991)

10.            Wahhab A., Smith J.R., Ganter R.C., Moore D.M., Hondrelis J., Matsoukas J.M., Moore G.J.: Drug Res. 43: 1157- 1168 (1993)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 1997 – ANNUAL SUBSCRIPTION 1997
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

Bookmark the permalink.

Comments are closed.